Tic-ing, Marivic .
HRN: 24-57-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2024
CO-AMOXICLAV 625MG (TAB)
02/12/2024
02/19/2024
PO
625mg
BID
2ND DEGREE RMLE; THINLY MECONIUM
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes